期刊文献+

36例初发2型糖尿病诺和灵强化治疗的临床分析 被引量:3

Chinical Analysis of 36 cases Primary Type Ⅱ diabetic Treated with Novelin
下载PDF
导出
摘要 目的:观察诺和灵强化治疗初发2型糖尿病的临床疗效。方法:69例2型糖尿病病人,随机分为2组,观察组36例:住院期间要求严格饮食控制、适当体育锻炼,同时均给予诺和灵30R三餐前、诺和灵N睡前皮下注射,血糖控制后改为诺和灵30R早晚二次,最少治疗3个月,最长坚持治疗6个月。然后根据血糖调整使用药物剂量。对照组33例:门诊治疗和随访,予以制定严格饮食控制、适当的体育锻炼计划;同时口服格列齐特,剂量根据血糖调整。每周门诊检测多点血糖、血压等1-2次。结果:观察组使用胰岛素血糖达标所用时间为(10±3)d,对照组为(21±7)d,经t检验(P〈0.05),差异有显著性。结论:诺和灵强化治疗初发2型糖尿病,快速降糖,解除高血糖毒性作用,促使胰岛B细胞分泌曲线恢复,降低胰岛素抵抗。 Objective:To observe the effect of novolin on Primary trpe 2 diabetrc patients. Method:69 cases were dirded in to ohservaition grorp(36 cases) and. cantral growp (33 cases), randomly. Ih observation growp. Novolin R. were injected three times befere dinner, subcutaneons injectror of Novolin N before sleep, in the mean while, diet cortral and proper exercise were adopbed. Afterg ly cermic were controlled. Novolin 30R was tiwece in the morning and evening, last for 1-2 to months. Then adjnstel the drtug dosage accoding to the glycermic. In the control growp: They were controlled diet, proper training exercise were under-went. with oral glielazide accordingto the glycemic. Examined the multipoint glycemic at clini, one week. Reswlt:There's sigmficant chfference (P〈0.05) betwaen observation growp (10±3) d. and control group (21±7) d. for the standard gly cemic level after llsing of in swlin. Conclusion : It can redwce the poison action of hypergly cemia, to treat primary type 2 diabetic with novolin.
出处 《河北医学》 CAS 2008年第5期575-578,共4页 Hebei Medicine
关键词 胰岛素 2型糖尿病 高血糖 Inswlin Type 2 diabetic Hyperglycemia
  • 相关文献

参考文献7

二级参考文献24

  • 1Zavaronl I,Bonini I.Hyperinsulinemia in a normal population as a predictor of non-insulin-dependent diabetes mellitus: the Barilla factory revisited.Metabolism,1999,48 (8) :984-994.
  • 2Pimenta W,Korytkowski M.Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM:ebidence from studies in normal glucose-tolerant individuals with first-degree NIDDM relatives.JAMA,1995,273(23):1855-1861.
  • 3Tripathy D,Carisson M.Insulin secretion and insulin sensitivity in relation to glucose tolerance.Boinia study.Diabetes,2000,49 (6 ): 975-980.
  • 4Kim DJ,Lee MS.Insulin secretory dysfunction and insulin resistance in the pathogenesis of Korean type 2 diabetes mellitus.Metabolism ,2001,50(5) :590-593.
  • 5Duman BS,Turkoglu C.The interrelationship between insulin secretion and action in type 2 diabetes mellitus with different degrees of obesity: evidence supporting central obesity.Diabetes Nutr Metab,2003,16 (4) :243-250.
  • 6Shin CS,Lee HK.Risk factors for the development of NIDDM in Younchon county,Korea.Diabetes Care,1997,20 (12): 1842-1846.
  • 7Fujimoto WY,Akanuma Y.Plasma insulin levels in Japanese and Japa nese-American men with type 2 diabetes may be related to the occur rence of cardiovascular disease.Diabetes Res Clin Pract,1989,6(2): 121-127.
  • 8UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood - glucose control with metformin on complications in overweight patients with type 2 diabetas, (UKPDS 34).Lancet 1998,352:854-865.
  • 9Yki-Jarvinen H. Kauppila M, Kujansuu E, et al. Comparison of insulin regimens in patients with non - insulin-dependent diabetes mellitus. N Engl J Med 1992,327:1426-1433.
  • 10Hermann LS. Combination therapy with insulin and metformin.Endocr Pract 1998,4:404-412.

共引文献42

同被引文献6

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部